An interventional study of stress-echocardiography and stress-MRI in Postmenopausal Women and Stable Angina Pectoris, sponsored by RWTH Aachen University. Completed at 1 site in Germany. Open to female participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2011-07-07.
Sponsored by RWTH Aachen University · Not applicable, Interventional, and Diagnostic
Aim of this study is the determination of a valid procedure for ischemia diagnositc in postmenopausal women.
In order to investigate which ischemia diagnostic presents which sensitivity and specificity for postmenopausal women, 100 consecutive patients presenting to our abmulance with stable angina pectoris and indication for myocardial szintigraphy will be enrolled in this study. An addidional stress-echocardiography and stress-MRI will be performed in this patients before they will reiceve their again routine coronay angiography.
The different methods for ischemia diagnostic will be compared in order to determine the most valid method for this specific population.
5,600 studies on the registry are indexed under Coronary Artery Disease; 958 are open to participants now.
This study's planned enrollment of 100 is below the median of 123 across 3,438 interventional studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →RWTH Aachen University is the lead sponsor of 228 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
stress-echocardiography will be performed once using Adenosin (140 µg/kg/min over 6 Minutes) and a contrast agent (SonoVue)
stress-MRI will be performed once using Adenosin (140 µg/kg/min over 6 Minutes)and a contrast agent (Gadovist)
comparision of different ischemia diagnostic methods
Time frame: before routine coronary angiography
This study is completed, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
RWTH Aachen University